Emergence of Bluetongue Virus Serotype 3, the Netherlands, September 2023
Melle Holwerda
1 , Inge M.G.A. Santman-Berends
1, Frank Harders, Marc Engelsma, Rianka P.M. Vloet, Eveline Dijkstra, Rene G.P. van Gennip, Maria H. Mars, Marcel Spierenburg, Lotte Roos, René van den Brom
1, and Piet A. van Rijn
1
Author affiliations: Wageningen Bioveterinary Research, Lelystad, the Netherlands (M. Holwerda, F. Harders, M. Engelsma, R.P.M. Vloet, R.G.P. van Gennip, P.A. van Rijn); Royal GD, Deventer, the Netherlands (I.M.G.A. Santman-Berends, E. Dijkstra, M.H. Mars, L. Roos, R. van den Brom); Netherlands Food and Consumer Product Safety Authority, Utrecht, the Netherlands (M. Spierenburg); North-West University, Potchefstroom, South Africa (P.A. van Rijn)
Main Article
Figure 1
Figure 1. Timeline of the initial bluetongue outbreak caused by BTV-3 in the Netherlands in September 2023. BTV, bluetongue virus; BTV-3, BTV serotype 3; EU, European Union; GD, Gezondheidsdienst voor Dieren; NVWA, Netherlands Food and Consumer Product Safety Authority; WBVR, Wageningen Bioveterinary Research; WGS, whole-genome sequencing.
Main Article
Page created: June 13, 2024
Page updated: July 20, 2024
Page reviewed: July 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.